Fabio
77 lines
5.2 KiB
Markdown
77 lines
5.2 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT."
|
||
description: "This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection."
|
||
jurisdiction: "us/states/de"
|
||
legislature: "Delaware General Assembly"
|
||
session: "149"
|
||
identifier: "SB 45"
|
||
citation: "Delaware SB 45 (149)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Bryan Townsend", "David Bentz"]
|
||
version_count: 1
|
||
action_count: 8
|
||
vote_count: 2
|
||
first_action: "2017-03-30"
|
||
last_action: "2017-07-17"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/69e7fc5f-11d3-4f07-90ff-ff6632a21bd2"
|
||
source_url: "https://legis.delaware.gov/BillDetail?LegislationId=25565"
|
||
source_hash: "155625ce6002fce5a1b70dd3b3a9009aa7aa86acb609f857a7ed06e6763bac1c"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-de"]
|
||
---
|
||
|
||
# Delaware SB 45 (149) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
|
||
|
||
This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Bill Text** (committee substitute) — [source](https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=25565&legislationTypeId=1&docTypeId=2&legislationName=SB45)
|
||
|
||
## Votes
|
||
|
||
- SM — **20–0** (pass) · upper
|
||
- SM — **40–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Bryan Townsend — primary (person)
|
||
- David Bentz — primary (person)
|
||
- Deborah Hudson — cosponsor (person)
|
||
- Debra Heffernan — cosponsor (person)
|
||
- Ernesto B Lopez — cosponsor (person)
|
||
- Gerald W. Hocker — cosponsor (person)
|
||
- Helene M. Keeley — cosponsor (person)
|
||
- Joseph E. Miro — cosponsor (person)
|
||
- Kimberly Williams — cosponsor (person)
|
||
- Ruth Briggs King — cosponsor (person)
|
||
- Stephanie L. Hansen — cosponsor (person)
|
||
- Trey Charles Paradee — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2017-03-30** Introduced and Assigned to Health, Children & Social Services Committee in Senate `introduction, referral-committee`
|
||
- **2017-04-05** Reported Out of Committee (Health, Children & Social Services) in Senate with 3 On Its Merits `committee-passage`
|
||
- **2017-04-26** Passed By Senate. Votes: 20 YES 1 ABSENT `passage`
|
||
- **2017-04-26** Passed By Senate. Votes: 20 YES 1 ABSENT `passage`
|
||
- **2017-04-27** Assigned to Health & Human Development Committee in House `introduction, referral-committee`
|
||
- **2017-05-03** Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits `committee-passage`
|
||
- **2017-05-18** Passed By House. Votes: 40 YES 1 ABSENT `passage`
|
||
- **2017-07-17** Signed by Governor `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/69e7fc5f-11d3-4f07-90ff-ff6632a21bd2`. Confidence: reported (aggregated from official Delaware legislature records).
|
||
|